Madison Sustainable Equity Fund highlighted stocks like Equifax Inc. (NYSE:EFX) in the Q3 2024 investor letter. Equifax Inc. ...

In a report released today, Andrew Steinerman from J.P. Morgan maintained a Buy rating on Equifax (EFX – Research Report), with a price target ...

Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver ...

Equifax Inc. (NYSE:EFX) shareholders might be concerned after seeing the share price drop 17% in the last quarter. But at least the stock is up over the last five years. However we are not very ...

Enerflex Ltd. (TSE:EFX – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday after Acumen Capital raised their price target on the stock from C$12.00 to C$15.00. The ...

On Friday, Equifax Inc (EFX) stock saw a decline, ending the day at $248.27 which represents a decrease of $-13.94 or -5.32% from the prior close of $262.21. The stock opened at $257.81 and touched a ...

Enerflex (TSE:EFX – Free Report) had its target price raised by BMO Capital Markets from C$11.00 to C$15.00 in a report ...

RBC Capital analyst Keith Mackey maintained a Buy rating on Enerflex (EFX – Research Report) today and set a price target of $12.00. The ...

The study revealed that after 96 weeks of EFX treatment, over 40% of participants exhibited regression of liver fibrosis, a key indicator of MASH progression. This includes improvements in liver ...

It has been about a month since the last earnings report for Equifax (EFX). Shares have lost about 6.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the ...